177 related articles for article (PubMed ID: 17897973)
1. Scottish court dismisses a historic smoker's suit.
Friedman L; Daynard R
Tob Control; 2007 Oct; 16(5):e4. PubMed ID: 17897973
[TBL] [Abstract][Full Text] [Related]
2. Tobacco manufacturers' defence against plaintiffs' claims of cancer causation: throwing mud at the wall and hoping some of it will stick.
Milberger S; Davis RM; Douglas CE; Beasley JK; Burns D; Houston T; Shopland D
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv17-26. PubMed ID: 17130620
[TBL] [Abstract][Full Text] [Related]
3. McTear v Imperial Tobacco: understanding the role and limitations of expert epidemiological evidence in scientific litigation.
Danne A
J Law Med; 2006 May; 13(4):471-8. PubMed ID: 16756216
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
Douglas CE; Davis RM; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
[TBL] [Abstract][Full Text] [Related]
5. Destroyed documents: uncovering the science that Imperial Tobacco Canada sought to conceal.
Hammond D; Chaiton M; Lee A; Collishaw N
CMAJ; 2009 Nov; 181(10):691-8. PubMed ID: 19828670
[TBL] [Abstract][Full Text] [Related]
6. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
Tong EK; England L; Glantz SA
Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
[TBL] [Abstract][Full Text] [Related]
7. Tobacco industry litigation position on addiction: continued dependence on past views.
Henningfield JE; Rose CA; Zeller M
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv27-36. PubMed ID: 17130621
[TBL] [Abstract][Full Text] [Related]
8. Testimony by otolaryngologists in defense of tobacco companies 2009-2014.
Jackler RK
Laryngoscope; 2015 Dec; 125(12):2722-9. PubMed ID: 26186270
[TBL] [Abstract][Full Text] [Related]
9. "Everyone knew but no one had proof": tobacco industry use of medical history expertise in US courts, 1990-2002.
Proctor RN
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv117-25. PubMed ID: 17130619
[TBL] [Abstract][Full Text] [Related]
10. The impact of strategic funding by the tobacco industry of medical expert witnesses appearing for the defence in the Aho Finnish product liability case.
Hiilamo HT
Addiction; 2007 Jun; 102(6):979-88. PubMed ID: 17523993
[TBL] [Abstract][Full Text] [Related]
11. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking.
Cummings KM; Morley CP; Hyland A
Tob Control; 2002 Mar; 11 Suppl 1(Suppl 1):I110-7. PubMed ID: 11893821
[TBL] [Abstract][Full Text] [Related]
12. Junking good science: undoing Daubert v Merrill Dow through cross-examination and argument.
Givelber D; Strickler L
Am J Public Health; 2006 Jan; 96(1):33-7. PubMed ID: 16317200
[TBL] [Abstract][Full Text] [Related]
13. The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
Goldberg ME; Davis RM; O'Keefe AM
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv54-67. PubMed ID: 17130625
[TBL] [Abstract][Full Text] [Related]
14. "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation.
Wakefield M; McLeod K; Perry CL
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv44-53. PubMed ID: 17130624
[TBL] [Abstract][Full Text] [Related]
15. The 'common knowledge' of Quebecers: quantifying the evidence of historians testifying for defendant tobacco companies.
Callard C
Tob Control; 2016 Sep; 25(5):492-7. PubMed ID: 26614760
[TBL] [Abstract][Full Text] [Related]
16. Product liability.
Daynard RA; Legresley E
Tob Control; 2012 Mar; 21(2):227-8. PubMed ID: 22345254
[TBL] [Abstract][Full Text] [Related]
17. The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.
Davis RM; Douglas CE; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv4-8. PubMed ID: 17130623
[TBL] [Abstract][Full Text] [Related]
18. Historians' testimony on "common knowledge" of the risks of tobacco use: a review and analysis of experts testifying on behalf of cigarette manufacturers in civil litigation.
Kyriakoudes LM
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv107-16. PubMed ID: 17130618
[TBL] [Abstract][Full Text] [Related]
19. How tobacco-friendly science escapes scrutiny in the courtroom.
Friedman LC; Daynard RA; Banthin CN
Am J Public Health; 2005; 95 Suppl 1():S16-20. PubMed ID: 16030332
[TBL] [Abstract][Full Text] [Related]
20. Economics on trial: the use and abuse of economic methods in third party tobacco litigation.
Max W; Tsoukalas T
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv77-83. PubMed ID: 17130627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
